Search research articles
Contact Us
Filters
Showing results (61-70 of 66) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 66 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer
S J Thompson, L Leigh, R Christensen, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 1999
Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors
W C Zamboni, L C Bowman, M Tan, et al.
Pediatric Neurosurgery
|
October 2, 1998
Bithalamic involvement predicts poor outcome among children with thalamic glial tumors
D A Reardon, A Gajjar, R A Sanford, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 1996
Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis
J S Taylor, J W Langston, W E Reddick, et al.
Cancer Research
|
October 27, 1997
Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization
D A Reardon, E Michalkiewicz, J M Boyett, et al.
Cancer
|
August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumors
S M Blaney, P C Phillips, R J Packer, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 66) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 66 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer
S J Thompson, L Leigh, R Christensen, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 1999
Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors
W C Zamboni, L C Bowman, M Tan, et al.
Pediatric Neurosurgery
|
October 2, 1998
Bithalamic involvement predicts poor outcome among children with thalamic glial tumors
D A Reardon, A Gajjar, R A Sanford, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 1996
Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis
J S Taylor, J W Langston, W E Reddick, et al.
Cancer Research
|
October 27, 1997
Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization
D A Reardon, E Michalkiewicz, J M Boyett, et al.
Cancer
|
August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumors
S M Blaney, P C Phillips, R J Packer, et al.
Page
of 7